X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12041) 12041
Publication (897) 897
Newsletter (95) 95
Book Review (83) 83
Book Chapter (14) 14
Conference Proceeding (12) 12
Dissertation (9) 9
Magazine Article (5) 5
Newspaper Article (2) 2
Book / eBook (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8820) 8820
female (4776) 4776
oncology (4765) 4765
index medicus (4481) 4481
male (4040) 4040
animals (3904) 3904
fluorouracil - pharmacology (3637) 3637
fluorouracil (3560) 3560
middle aged (3268) 3268
fluorouracil - administration & dosage (3166) 3166
chemotherapy (3107) 3107
5-fluorouracil (3102) 3102
aged (2812) 2812
cancer (2798) 2798
adult (2357) 2357
antineoplastic combined chemotherapy protocols - therapeutic use (2227) 2227
mice (2210) 2210
fluorouracil - therapeutic use (2150) 2150
cell line, tumor (1786) 1786
pharmacology & pharmacy (1665) 1665
colorectal cancer (1545) 1545
colorectal neoplasms - drug therapy (1444) 1444
fluorouracil - metabolism (1425) 1425
treatment outcome (1272) 1272
apoptosis (1269) 1269
expression (1134) 1134
antineoplastic agents - pharmacology (1130) 1130
prognosis (1103) 1103
antimetabolites, antineoplastic - pharmacology (1063) 1063
rats (1016) 1016
fluorouracil - pharmacokinetics (989) 989
research (988) 988
fluorouracil - analogs & derivatives (984) 984
apoptosis - drug effects (967) 967
fluorouracil - adverse effects (956) 956
care and treatment (951) 951
deoxycytidine - analogs & derivatives (948) 948
colorectal neoplasms - pathology (943) 943
breast neoplasms - drug therapy (939) 939
capecitabine (928) 928
analysis (926) 926
carcinoma (862) 862
antimetabolites, antineoplastic - therapeutic use (845) 845
antineoplastic agents - therapeutic use (815) 815
medicine & public health (815) 815
dose-response relationship, drug (811) 811
therapy (804) 804
aged, 80 and over (799) 799
tumors (777) 777
leucovorin (758) 758
colorectal-cancer (754) 754
cell proliferation - drug effects (724) 724
time factors (723) 723
breast cancer (718) 718
biochemistry & molecular biology (716) 716
metastasis (710) 710
survival (695) 695
colonic neoplasms - drug therapy (690) 690
tumor cells, cultured (687) 687
colorectal neoplasms - metabolism (684) 684
drug synergism (672) 672
neoplasm staging (672) 672
antineoplastic combined chemotherapy protocols - adverse effects (670) 670
oxaliplatin (667) 667
thymidylate synthase (659) 659
drug resistance, neoplasm (652) 652
camptothecin - analogs & derivatives (646) 646
health aspects (633) 633
cell survival - drug effects (627) 627
antineoplastic combined chemotherapy protocols - administration & dosage (622) 622
disease-free survival (619) 619
surgery (615) 615
adenocarcinoma - drug therapy (611) 611
stomach neoplasms - drug therapy (611) 611
mice, nude (607) 607
neoplasms - drug therapy (606) 606
cells (605) 605
toxicity (593) 593
immunohistochemistry (589) 589
leucovorin - administration & dosage (587) 587
gene expression (574) 574
chemotherapy, adjuvant (564) 564
cisplatin (555) 555
cell biology (537) 537
drug therapy (537) 537
colorectal neoplasms - genetics (532) 532
mice, inbred balb c (527) 527
pharmacokinetics (526) 526
dihydropyrimidine dehydrogenase (524) 524
breast neoplasms - pathology (521) 521
cisplatin - administration & dosage (520) 520
antimetabolites, antineoplastic - administration & dosage (518) 518
breast neoplasms - metabolism (518) 518
drug administration schedule (516) 516
colon cancer (515) 515
deoxycytidine - administration & dosage (515) 515
thymidylate synthase - metabolism (514) 514
proteins (504) 504
survival rate (498) 498
genetic aspects (497) 497
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11346) 11346
Japanese (370) 370
Chinese (170) 170
Russian (88) 88
German (65) 65
French (64) 64
Italian (9) 9
Polish (8) 8
Hungarian (6) 6
Spanish (6) 6
Korean (4) 4
Czech (2) 2
Danish (2) 2
Turkish (2) 2
Dutch (1) 1
Hebrew (1) 1
Norwegian (1) 1
Portuguese (1) 1
Romanian (1) 1
Slovak (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunity, ISSN 1074-7613, 12/2012, Volume 37, Issue 6, pp. 1009 - 1023
Cytopenias are key prognostic indicators of life-threatening infection, contributing to immunosuppression and mortality. Here we define a role for... 
NALP1 | LETHAL TOXIN | IN-VIVO | DISEASE | BINDING-PROTEIN | DEATH | INFECTION | IMMUNOLOGY | TIR DOMAIN | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | CASPASE-1 ACTIVATION | Inflammasomes - metabolism | Cytoskeletal Proteins - genetics | Dermatitis - immunology | Pancytopenia - immunology | Caspase 1 - metabolism | Interferon-gamma - metabolism | Hematopoiesis - drug effects | Inflammation - metabolism | T-Lymphocytes - metabolism | Interleukin-1beta - metabolism | Apoptosis Regulatory Proteins - genetics | Cytoskeletal Proteins - metabolism | Hematopoietic Stem Cells - virology | Hematopoietic Stem Cells - drug effects | Hematopoietic Stem Cells - metabolism | Inflammation - immunology | Apoptosis Regulatory Proteins - metabolism | Mice, Knockout | Pancytopenia - metabolism | Hematopoiesis - immunology | Animals | CARD Signaling Adaptor Proteins | Adaptor Proteins, Signal Transducing - genetics | Inflammation - genetics | T-Lymphocytes - immunology | Fluorouracil - pharmacology | Mice | Mutation | Adaptor Proteins, Signal Transducing - metabolism | Interleukin-18 - metabolism | Apoptosis | Dermatitis - metabolism | Chemotherapy | Research | Health aspects | Oncology, Experimental | Immunotherapy | Cancer | Proteins | Medical research | Disease | Councils | Bone marrow | Infections | Grants | Kinases | pyroptosis | inflammasome | IL-18 | progenitor cells | NLRP1 | cytopenia | IL-1β | sepsis
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 05/2018, Volume 46, Issue 4, pp. 1628 - 1642
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2009, Volume 16, Issue 12, pp. 3488 - 3498
Cancer stem cells are associated with metastatic potential, treatment resistance, and poor patient prognosis. Distant recurrence remains the major cause of... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | PHARMACOKINETIC MODULATING CHEMOTHERAPY | PLURIPOTENT STEM-CELLS | COLON-CANCER | SURGERY | CARCINOMA CELLS | MESSENGER-RNA | ONCOLOGY | MARKER CD133 | TUMOR-REGRESSION | PREOPERATIVE CHEMORADIOTHERAPY | EXPRESSION | TOTAL MESORECTAL EXCISION | Colonic Neoplasms - radiotherapy | Neoplasm Recurrence, Local - radiotherapy | Neoplasm, Residual - metabolism | Prognosis | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Glycoproteins - metabolism | Peptides - genetics | Neoplasm Recurrence, Local - drug therapy | Male | RNA, Messenger - metabolism | Antigens, CD - genetics | Colonic Neoplasms - metabolism | Immunoenzyme Techniques | Antigens, CD - metabolism | SOXB1 Transcription Factors - metabolism | Octamer Transcription Factor-3 - genetics | Fluorouracil - administration & dosage | Peptides - metabolism | Uracil - administration & dosage | SOXB1 Transcription Factors - genetics | Biomarkers, Tumor - metabolism | Adult | Female | Neoplasm, Residual - radiotherapy | Retrospective Studies | Tumor Cells, Cultured | Rectal Neoplasms - drug therapy | Glycoproteins - genetics | Radiotherapy Dosage | Neoplasm Recurrence, Local - metabolism | RNA, Messenger - genetics | Survival Rate | Combined Modality Therapy | Lymphatic Metastasis | Reverse Transcriptase Polymerase Chain Reaction | AC133 Antigen | Rectal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Octamer Transcription Factor-3 - metabolism | Neoplasm, Residual - drug therapy | Tegafur - administration & dosage | Aged | Rectal Neoplasms - metabolism | Neoplasm Staging | Immunohistochemistry | Medical colleges | Care and treatment | Colon cancer | Radiation | Stem cells | Metastasis | Health aspects | Cancer
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2014, Volume 20, Issue 4, pp. 837 - 846
Purpose: Metastasis and drug resistance are the major limitations in the survival and management of patients with cancer. This study aimed to identify the... 
YES-ASSOCIATED PROTEIN | 1ST-LINE TREATMENT | METASTASIS | ONCOLOGY | COLORECTAL-CANCER | GROWTH | RESISTANCE | SELF-RENEWAL | YAP | IRINOTECAN | FLUOROURACIL | Cell Proliferation | Neoplastic Stem Cells - drug effects | Colonic Neoplasms - drug therapy | Humans | Drug Resistance, Neoplasm | Liver Neoplasms - mortality | Colonic Neoplasms - metabolism | Checkpoint Kinase 2 - metabolism | Fluorouracil - therapeutic use | Cell Nucleus - metabolism | Neoplastic Stem Cells - metabolism | Proto-Oncogene Proteins c-yes - genetics | Biomarkers, Tumor - metabolism | Antimetabolites, Antineoplastic - pharmacology | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Neoplasm Micrometastasis - prevention & control | Nuclear Proteins - genetics | Colonic Neoplasms - mortality | Gene Expression | Proto-Oncogene Proteins c-yes - metabolism | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Nuclear Proteins - metabolism | Transcription Factors - genetics | Protein Transport | HT29 Cells | Transcription Factors - metabolism | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Cell Cycle Checkpoints | Colonic Neoplasms - pathology | Liver Neoplasms - metabolism | Fluorouracil - pharmacology | Index Medicus | Adjuvant chemotherapy | Colon liver metastases | Predictive survival markers | Chemoresistance | Colon cancer stem cells
Journal Article
Cell, ISSN 0092-8674, 04/2017, Volume 169, Issue 3, pp. 442 - 456.e18
Journal Article
Nature Medicine, ISSN 1078-8956, 01/2013, Volume 19, Issue 1, pp. 57 - 64
Chemotherapeutic agents are widely used for cancer treatment. In addition to their direct cytotoxic effects, these agents harness the host's immune system,... 
MEDICINE, RESEARCH & EXPERIMENTAL | CANCER-CHEMOTHERAPY | ANGIOGENESIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GEMCITABINE | BETA | CELL BIOLOGY | 5-FLUOROURACIL | INHIBITION | MICROENVIRONMENT | ANTITUMOR IMMUNITY | BEARING MICE | T-CELLS | Neoplasms - metabolism | Cell Proliferation | Inflammasomes - metabolism | NLR Family, Pyrin Domain-Containing 3 Protein | Cathepsin B - genetics | Humans | Caspase 1 - metabolism | Deoxycytidine - pharmacology | Signal Transduction - immunology | Neoplasms - genetics | RNA Interference | Female | Antineoplastic Agents - pharmacology | Interleukin-1beta - biosynthesis | Dendritic Cells - metabolism | bcl-2-Associated X Protein - genetics | Interleukin-17 - secretion | Mice, Inbred C57BL | CD4-Positive T-Lymphocytes - metabolism | Cathepsin B - metabolism | Mice, Knockout | Carrier Proteins - genetics | Macrophages - metabolism | Animals | Carrier Proteins - metabolism | Caspase 1 - genetics | Cell Line, Tumor | Fluorouracil - pharmacology | Mice | Mice, Inbred BALB C | RNA, Small Interfering | Receptors, Interleukin-1 - antagonists & inhibitors | Deoxycytidine - analogs & derivatives | Chemotherapy | Gemcitabine | Cathepsins | Physiological aspects | Dosage and administration | Research | Health aspects | Fluorouracil | Cancer | Cells | Inflammatory diseases | Tumors | Engineering Sciences | Automatic
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2019, Volume 144, Issue 4, pp. 897 - 908
Journal Article